Article
At the Leiden Bio Science Park in the Netherlands, a modern office building has been constructed using the latest technology, providing a hybrid working environment conducive to innovation and collaboration. The Global Real Estate unit of Credit Suisse Asset Management has acquired this single-tenant building.
November 2, 2023
The life sciences market is booming worldwide. Demographic change, the rise in the incidence of chronic diseases and increasing health awareness after COVID-19 are all factors equally responsible for this development. The life sciences industry is working hard to develop the relevant drugs and vaccines, and is enjoying rapid growth. This has resulted in huge demand for suitable new locations and real estate that can meet the specific needs of this sector.
Credit Suisse Asset Management is following this trend and around two years ago acquired the project at the Leiden Bio Science Park in the Netherlands. Over the years, Leiden has become the largest knowledge cluster in the field of life sciences and health in the Netherlands. It is also home to the country's oldest university.
The turnkey property was delivered to Credit Suisse Asset Management on 1 June 2023. The new tenant, Janssen Biologics B.V., is owned by Johnson & Johnson, one of the world's largest healthcare companies with annual revenues of more than USD 80 billion.
The tenant is currently fitting out the building. The laboratories are still being equipped and are expected to be ready in November 2023. The building offers a total gross area of approximately 13,500 square meters and a rentable area of some 11,300 square meters. Parking facilities and the entrance are located on the ground floor, laboratory areas are planned for levels 1 and 2, and levels 3, 4 and 5 will contain spacious office areas.
Sustainability principles already incorporated into the building project at the design stage
Health, safety, collaboration and transparency are important aspects that had to be taken into account in the new building. This proved to be particularly challenging when it came to the laboratory areas. Thanks to an intelligent and sustainable design, the property sets new standards for the 21st century working environment.
The building has an efficient and flexible floor plan to optimally support the various departments of the new tenant, with innovation and collaboration as the most important spearheads. The generous future-proof workspaces are surrounded by various building-related facilities such as a spacious and bright atrium, a roof garden and a company restaurant. Large flexible floor areas ensure a feeling of open space. The laboratory area can be relatively easy transformed into office space, should this be required in the future.
Globally recognized assessment systems were incorporated during the construction of the highly advanced, sustainable and healthy building: BREEAM for sustainability and WELL for health and well-being both inside and outside of the building. One particular example of the sustainability approach chosen is that the building has not been connected to the gas grid. Instead, it has an ATES (aquifer thermal energy storage) system, which can store heat and cold in the ground beneath the building.
However, the building impresses not only because of its efficient energy and water consumption and the reduction of CO₂ emissions, but also in terms of ensuring the well-being of the employees that work there. In this regard, the focus was on providing a healthy indoor climate as well as a comfortable and varied working environment. The BREEAM Excellent and WELL Gold certificates awarded to the building are evidence of the high standard that has been achieved.1
Find investment products that suit your personal needs. Choose from our extensive range of investment solutions across all major asset classes, and access all product-related information.
You can also follow a fund and receive the monthly factsheet quickly and easily.
Contact us to learn about exciting investment opportunities. We are here to help you achieve your investment goals.
The individual company mentioned on this page is meant for illustration purposes only and is not intended as a solicitation or an offer to buy or sell any interest or any investment.
Source: Credit Suisse, unless otherwise specified.
Unless noted otherwise, all illustrations in this document were produced by Credit Suisse AG and/or its affiliates with the greatest of care and to the best of its knowledge and belief.
This material constitutes marketing material of Credit Suisse AG and/or its affiliates (hereafter "CS"). This material does not constitute or form part of an offer or invitation to issue or sell, or of a solicitation of an offer to subscribe or buy, any securities or other financial instruments, or enter into any other financial transaction, nor does it constitute an inducement or incitement to participate in any product, offering or investment. This marketing material is not a contractually binding document or an information document required by any legislative provision. Nothing in this material constitutes investment research or investment advice and may not be relied upon. It is not tailored to your individual circumstances, or otherwise constitutes a personal recommendation, and is not sufficient to take an investment decision. The information and views expressed herein are those of CS at the time of writing and are subject to change at any time without notice. They are derived from sources believed to be reliable. CS provides no guarantee with regard to the content and completeness of the information and where legally possible does not accept any liability for losses that might arise from making use of the information. If nothing is indicated to the contrary, all figures are unaudited. The information provided herein is for the exclusive use of the recipient. The information provided in this material may change after the date of this material without notice and CS has no obligation to update the information. This material may contain information that is licensed and/or protected under intellectual property rights of the licensors and property right holders. Nothing in this material shall be construed to impose any liability on the licensors or property right holders. Unauthorised copying of the information of the licensors or property right holders is strictly prohibited. This material may not be forwarded or distributed to any other person and may not be reproduced. Any forwarding, distribution or reproduction is unauthorized and may result in a violation of the U.S. Securities Act of 1933, as amended (the “Securities Act”). In addition, there may be conflicts of interest with regard to the investment. In connection with the provision of services, Credit Suisse AG and/or its affiliates may pay third parties or receive from third parties, as part of their fee or otherwise, a one-time or recurring fee (e.g., issuing commissions, placement commissions or trailer fees). Prospective investors should independently and carefully assess (with their tax, legal and financial advisers) the specific risks described in available materials, and applicable legal, regulatory, credit, tax and accounting consequences prior to making any investment decision.
Copyright © 2023 CREDIT SUISSE. All rights reserved.
Distributor: Credit Suisse (Switzerland) Ltd., Paradeplatz 8, CH-8001 Zurich I Distributor: Credit Suisse AG, Paradeplatz 8, CH-8001 Zurich I Distributor: Credit Suisse Asset Management (Switzerland) Ltd., Kalandergasse 4, CH-8045 Zurich I Supervisor (Entity of Registration): Swiss Financial Market Supervisory Authority (FINMA)
